Summer Sale

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Get 30% Off

Up to 30% off — ends 7 Aug

ONLY00h00m00s

Zhoumeng Lin

Associate Professor

University of Florida

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do I reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Academic Page

Research Interests

Pharmacology

100%

Environmental Chemistry

40%

Pharmacokinetic

100%

Toxicology

60%

Biokinetics

50%

Kinetics Modeling

40%

Nanotoxicology

40%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles28

Application of Lactation Physiologically Based Pharmacokinetic Modeling to Predict Milk Exposure of Passively Diffused Drugs

Article Link

Year:

2025

A Physiologically Based Pharmacokinetic Model of an Oral Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Adults

Article Link

Year:

2025

Mechanistic Modeling of Size and Surface Charge Changes of Gold and Silver Nanoparticles during In Vitro Nanoparticle Protein Corona Formation

Article Link

Year:

2025

Machine Learning and Artificial Intelligence in Nanomedicine

Article Link

Year:

2025

An open-source interactive physiologically based pharmacokinetic model of tylosin in broiler chickens and laying hens

Article Link

Year:

2025

A Machine Learning–Based Clustering Analysis to Explore Bisphenol A and Phthalate Exposure from Medical Devices in Infants with Congenital Heart Defects

Article Link

Year:

2025

Comparisons of PK-Sim and R program for physiologically based pharmacokinetic model development for broiler chickens and laying hens: meloxicam as a case study

Article Link

Year:

2025

Chemical risk assessment in food animals via physiologically based pharmacokinetic modeling – Part II: Environmental pollutants on animal and human health assessments

Article Link

Year:

2025

Development of a physiologically based pharmacokinetic model for flunixin in cattle and swine following dermal exposure

Article Link

Year:

2025

Development of machine learning-based quantitative structure–activity relationship models for predicting plasma half-lives of drugs in six common food animal species

Article Link

Year:

2025

Residue depletion profiles and withdrawal intervals of florfenicol and its metabolite florfenicol amine in plasma and milk of lactating goats after repeated subcutaneous administrations

Article Link

Year:

2024

Physiologically based pharmacokinetic modeling of metal nanoparticles for risk assessment of inhalation exposures: a state-of-the-science expert panel review

Article Link

Year:

2024

Preface to the special issue of Food and Chemical Toxicology on “New approach methodologies and machine learning in food safety and chemical risk assessment: Development of reproducible, open-source, and user-friendly tools for exposure, toxicokinetic, and toxicity assessments in the 21st century”

Article Link

Year:

2024

Exploring the potential and challenges of developing physiologically-based toxicokinetic models to support human health risk assessment of microplastic and nanoplastic particles

Article Link

Year:

2024

Impact of protein coronas on nanoparticle interactions with tissues and targeted delivery

Article Link

Year:

2024

Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling

Article Link

Year:

2023

Development of machine learning algorithms to estimate maximum residue limits for veterinary medicines

Article Link

Year:

2023

Pharmacokinetics and tumor delivery of nanoparticles

Article Link

Year:

2023

Pharmacokinetics, Milk Residues, and Toxicological Evaluation of a Single High Dose of Meloxicam Administered at 30 mg/kg per os to Lactating Dairy Cattle

Article Link

Year:

2023

Development and application of an interactive generic physiologically based pharmacokinetic (igPBPK) model for adult beef cattle and lactating dairy cows to estimate tissue distribution and edible tissue and milk withdrawal intervals for per- and polyfluoroalkyl substances (PFAS)

Article Link

Year:

2023

Pharmacokinetics, tissue residue depletion, and withdrawal interval estimations of florfenicol in goats following repeated subcutaneous administrations

Article Link

Year:

2023

Meta-Analysis of Nanoparticle Distribution in Tumors and Major Organs in Tumor-Bearing Mice

Article Link

Year:

2023

Development of a multi-route physiologically based pharmacokinetic (PBPK) model for nanomaterials: a comparison between a traditional versus a new route-specific approach using gold nanoparticles in rats

Article Link

Year:

2022

Machine Learning and Artificial Intelligence in Toxicological Sciences

Article Link

Year:

2022

An Interactive Generic Physiologically Based Pharmacokinetic (igPBPK) Modeling Platform to Predict Drug Withdrawal Intervals in Cattle and Swine: A Case Study on Flunixin, Florfenicol, and Penicillin G

Article Link

Year:

2022

Integration of In Vitro and In Vivo Models to Predict Cellular and Tissue Dosimetry of Nanomaterials Using Physiologically Based Pharmacokinetic Modeling

Article Link

Year:

2022

Toxicokinetics, dose–response, and risk assessment of nanomaterials: Methodology, challenges, and future perspectives

Article Link

Year:

2022

A web-based interactive physiologically based pharmacokinetic (iPBPK) model for meloxicam in broiler chickens and laying hens

Article Link

Year:

2022

Collaborators8

Michael Kleinhenz

Texas A&M University

UNITED STATES

Lisa Tell

department of epidemiology and biostatistics university of california san francisco san francisco california usa

UNITED STATES

Wei-Chun Chou

Research Assistant Professor

University of Florida

UNITED STATES

Majid Jaberi-Douraki

UNITED STATES

Ronald Baynes

UNITED STATES

Xuan Xu

UNITED STATES

Nancy Monteiro-Riviere

Professor Investigative Dermatology and Toxicology

North Carolina State University

UNITED STATES

Patrick J. Gorden

UNITED STATES

How do I reach out?

Meet Kite AI